eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam

NCT01484977 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Lacosamide

Sponsor

UCB Pharma